Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity

Toxicol Appl Pharmacol. 2004 Oct 1;200(1):16-26. doi: 10.1016/j.taap.2004.02.001.

Abstract

Gene expression patterns using microarrays have been described for rodent models of nephrotoxicity. To determine if significant gene expression changes previously identified have application across multiple species, we studied quantitative gene expression changes in the kidneys of female cynomolgus monkeys after exposure to two nephrotoxicants. Animals were dosed with the aminoglycoside gentamicin (10 mg/kg), the experimental oligosaccharide antibiotic everninomicin (30 or 60 mg/kg), or a combination of gentamicin (10 mg/kg) and everninomicin (30 mg/kg) for 7 days. Monkeys receiving these drugs in combination developed renal lesions as early as Day 1. By Day 7, monkeys dosed with 60 mg/kg everninomicin alone also developed renal lesions, while the group exposed to both compounds had more extensive renal damage. The modulation of several genes previously reported to be associated with nephrotoxicity in rodent models was confirmed using quantitative real-time PCR. Among these, waf-1, matrix metalloproteinase-9, and vimentin exhibited changes consistent with the definition of a genomic indicator of toxicity. In addition, we identified three early gene biomarkers that may be predictive of drug-induced nephrotoxicity: clusterin, osteopontin, and hepatitis A virus cellular receptor-1. Logistic regression demonstrated a high degree of correlation between changes in gene expression and the probability of the development of histopathologic lesions. These results are the first confirming rodent gene expression changes associated with nephrotoxicity in a nonhuman primate model and provide preliminary evidence for identifying early gene expression changes predicting the onset of drug-induced renal tubular damage in cynomolgus monkeys.

MeSH terms

  • Aminoglycosides / pharmacology
  • Animals
  • Anti-Bacterial Agents*
  • Clusterin
  • DNA, Complementary / biosynthesis
  • DNA, Complementary / genetics
  • Gene Expression / drug effects*
  • Genetic Markers
  • Glycoproteins / metabolism
  • Hepatitis A Virus Cellular Receptor 1
  • Kidney / enzymology
  • Kidney / pathology
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / genetics*
  • Kidney Diseases / pathology
  • Macaca fascicularis
  • Membrane Glycoproteins / metabolism
  • Molecular Chaperones / metabolism
  • Osteopontin
  • RNA, Messenger / analysis
  • RNA, Messenger / biosynthesis
  • Receptors, Virus / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sialoglycoproteins / metabolism

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Clusterin
  • DNA, Complementary
  • Genetic Markers
  • Glycoproteins
  • HAVCR1 protein, human
  • Hepatitis A Virus Cellular Receptor 1
  • Membrane Glycoproteins
  • Molecular Chaperones
  • RNA, Messenger
  • Receptors, Virus
  • SPP1 protein, human
  • Sialoglycoproteins
  • Osteopontin
  • evernimicin